FDA Episodes

Nov. 16, 2023

546: New Youth Tobacco Data, Celebrate Rural Health

Charla Sutton, senior analyst for Chronic Disease Risk Factors at ASTHO, tracks the latest National Youth Tobacco Survey’s encouraging results; Chris Salyers, director of Programs and Evaluation at the National Organization …
Oct. 19, 2023

527: Disaster Exercise Toolkit, Healthy Brain Resources

Jennifer Lynch, Emergency Management Specialist with the Federal Emergency Management Agency, says the frequency and intensity of natural disasters is changing the way planners think about emergency response; Nathan Wormingt…
Aug. 21, 2023

486: Over-the-Counter Naloxone, Hurricane Partnerships

Richa Ranade, ASTHO’s Senior Director of Overdose Prevention, says ASTHO’s policy statement on over-the-counter naloxone supports increasing access; Chris Medina, State Medical Operations Center Director at the Texas Departm…
June 26, 2023

448: Vital Records Accreditation Matters, Therapeutic Psilocybin Programs Gain Traction

Mariah Pokorny, Director of Accreditation & Reporting for the South Dakota Department Of Health, explains the importance of vital records and health statistics accreditation; Chantell Reed, Interim Deputy Director Of Operati…
May 25, 2023

428: FDA Meets on Drug Shortages

Dr. Marcus Plescia, ASTHO Chief Medical Officer, says drug shortages are on the docket for the FDA meeting in Chicago; and today is the last day to register to attend ASTHO’s TechXpo and Futures Forum online.
Sept. 14, 2021

25: FDA’s E-Cigarette Review

Jeffrey Ekoma, ASTHO’s Director of Government Affairs, discusses the FDA’s move to delay a decision on marketing applications for some flavored e-cigarette products; Melissa McGrath, Chief of Staff for the Council of Chief S…